Login
|
New Account
AAAAAA
ITA
ENG
Results:
<<
|
201-225
|
226-250
|
251-275
|
276-300
|
>>
Table of contents of journal:
*Molecular medicine today (Regular ed.)
Results: 201-225/784
Blocking HIV-1 infection with intrakines
Authors:
Dorrell, S
Citation:
S. Dorrell, Blocking HIV-1 infection with intrakines, MOL MED TOD, 5(3), 1999, pp. 97-97
How much molecular medicine do medical students need to learn?
Authors:
Brooksbank, C
Citation:
C. Brooksbank, How much molecular medicine do medical students need to learn?, MOL MED TOD, 5(3), 1999, pp. 100-100
Biochemistry versus molecular medicine: what should we be teaching our medical students?
Authors:
Papavassiliou, AG
Citation:
Ag. Papavassiliou, Biochemistry versus molecular medicine: what should we be teaching our medical students?, MOL MED TOD, 5(3), 1999, pp. 100-101
Integrating molecular medicine into the medical school curriculum
Authors:
Smith, HC Hundert, EM
Citation:
Hc. Smith et Em. Hundert, Integrating molecular medicine into the medical school curriculum, MOL MED TOD, 5(3), 1999, pp. 102-103
Medical education: catering for the carers as well as the innovators
Authors:
Cox, TB
Citation:
Tb. Cox, Medical education: catering for the carers as well as the innovators, MOL MED TOD, 5(3), 1999, pp. 103-104
The palmoplantar keratodermas: much more than palms and soles
Authors:
Kelsell, DP Stevens, HP
Citation:
Dp. Kelsell et Hp. Stevens, The palmoplantar keratodermas: much more than palms and soles, MOL MED TOD, 5(3), 1999, pp. 107-113
Applications of telomerase research in the fight against cancer
Authors:
McKenzie, KE Umbricht, CB Sukumar, S
Citation:
Ke. Mckenzie et al., Applications of telomerase research in the fight against cancer, MOL MED TOD, 5(3), 1999, pp. 114-122
The molecular pathogenesis of endotoxic shock and organ failure
Authors:
Karima, R Matsumoto, S Higashi, H Matsushima, K
Citation:
R. Karima et al., The molecular pathogenesis of endotoxic shock and organ failure, MOL MED TOD, 5(3), 1999, pp. 123-132
The diagnosis and treatment of osteoporosis: future prospects
Authors:
Baylink, DJ Strong, DD Mohan, S
Citation:
Dj. Baylink et al., The diagnosis and treatment of osteoporosis: future prospects, MOL MED TOD, 5(3), 1999, pp. 133-140
Human embryonic stem cells: the future of transplantation medicine?
Authors:
Senior, K
Citation:
K. Senior, Human embryonic stem cells: the future of transplantation medicine?, MOL MED TOD, 5(2), 1999, pp. 47-48
Targeting protein breakdown to treat cancer
Authors:
Bonn, D
Citation:
D. Bonn, Targeting protein breakdown to treat cancer, MOL MED TOD, 5(2), 1999, pp. 48-49
Virus buster for transfusion blood
Authors:
Dorrell, S
Citation:
S. Dorrell, Virus buster for transfusion blood, MOL MED TOD, 5(2), 1999, pp. 49-50
Turning off RB for a healthy heart?
Authors:
Fricker, J
Citation:
J. Fricker, Turning off RB for a healthy heart?, MOL MED TOD, 5(2), 1999, pp. 50-51
Is extravasation a Fas-regulated process?
Authors:
Walsh, K Sata, M
Citation:
K. Walsh et M. Sata, Is extravasation a Fas-regulated process?, MOL MED TOD, 5(2), 1999, pp. 61-67
Urinary analyte screening: a noninvasive detection method for Down syndrome?
Authors:
Canick, JA Kellner, LH Cole, LA Cuckle, HS
Citation:
Ja. Canick et al., Urinary analyte screening: a noninvasive detection method for Down syndrome?, MOL MED TOD, 5(2), 1999, pp. 68-73
New perspectives on the etiology of systemic sclerosis
Authors:
Artlett, CM Smith, JB Jimenez, SA
Citation:
Cm. Artlett et al., New perspectives on the etiology of systemic sclerosis, MOL MED TOD, 5(2), 1999, pp. 74-78
Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders?
Authors:
Inui, A
Citation:
A. Inui, Neuropeptide Y: a key molecule in anorexia and cachexia in wasting disorders?, MOL MED TOD, 5(2), 1999, pp. 79-85
Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer
Authors:
van Steeg, H Kraemer, KH
Citation:
H. Van Steeg et Kh. Kraemer, Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer, MOL MED TOD, 5(2), 1999, pp. 86-94
Gelsolin: a new marker for breast cancer?
Authors:
Habeck, M
Citation:
M. Habeck, Gelsolin: a new marker for breast cancer?, MOL MED TOD, 5(12), 1999, pp. 503-503
Mice illuminate the pathways to lupus
Authors:
Sansom, C
Citation:
C. Sansom, Mice illuminate the pathways to lupus, MOL MED TOD, 5(12), 1999, pp. 504-505
Heart disease linked to oestrogen-receptor gene methylation
Authors:
Fricker, J
Citation:
J. Fricker, Heart disease linked to oestrogen-receptor gene methylation, MOL MED TOD, 5(12), 1999, pp. 505-506
The complex puzzle of gene variation and essential hypertension
Authors:
Senior, K
Citation:
K. Senior, The complex puzzle of gene variation and essential hypertension, MOL MED TOD, 5(12), 1999, pp. 506-506
Neurodegenerative disease: a different view of diagnosis
Authors:
Hardy, J Gwinn-Hardy, K
Citation:
J. Hardy et K. Gwinn-hardy, Neurodegenerative disease: a different view of diagnosis, MOL MED TOD, 5(12), 1999, pp. 514-517
The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?
Authors:
Acton, SL Kozarsky, KF Rigotti, A
Citation:
Sl. Acton et al., The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?, MOL MED TOD, 5(12), 1999, pp. 518-524
The neuroprotective potential of heat shock protein 70 (HSP70)
Authors:
Yenari, MA Giffard, RG Sapolsky, RM Steinberg, GK
Citation:
Ma. Yenari et al., The neuroprotective potential of heat shock protein 70 (HSP70), MOL MED TOD, 5(12), 1999, pp. 525-531
Risultati:
<<
|
201-225
|
226-250
|
251-275
|
276-300
|
>>